Automera
PrivateLast Round
Seed
Aug 7, 2026
Total Funding Raised
$16M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Automera is a biotechnology company that develops autophagy-targeting chimera small molecules (AUTACs) for targeted protein degradation to treat cancer, inflammation, and central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Automera Comparables
Compare Automera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AUTOTAC Bio | 89% | |
| Casma Therapeutics | 86% | |
| Attec Biotech | 85% |
Automera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 7, 2026 | ||||
| Series A | Sep 27, 2023 |
Automera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accelerator Life Science Partners | Series A |
| Xora Innovation | Series A |
| ClavystBio | Series A |
| EDBI | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 145% MoM, reaching 2.6K.
- Aug 7, 2026
$1M raised in Seed Round.
Automera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Automera's valuation, stock price, and market status.
Is Automera a public or private company?
Automera is a private company.
What is the current stock price of Automera?
Automera is a private company with no public stock price. No recent secondary market data is available.
How much is Automera worth (valuation)?
Valuation information for Automera is not publicly available.
Can I buy Automera stock?
Automera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Automera's last funding round?
Automera's most recent funding round was Series A on September 26, 2023.
Who are the main investors in Automera?
Key investors in Automera include Accelerator Life Science Partners, ClavystBio.
Will Automera IPO soon?
No public IPO plans have been announced for Automera.
How can I track Automera secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Automera's secondary market activity and sign up for updates.